Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The study drug, Aprepitant, is currently used to control chemotherapy induced nausea and vomiting and is also approved for post-operative nausea and vomiting. The investigators\' evaluation of it in morbidly obese patients will demonstrate its ability to control nausea and vomiting post-operatively in this subset of patients.
Epistemonikos ID: f54852b6d1d0031b896c36d7c91e3fa7f6577e28
First added on: May 05, 2024